Search results
Results from the WOW.Com Content Network
Drug Discovery Today is a monthly peer-reviewed scientific journal that is published by Elsevier.It was established in 1996 and publishes reviews on all aspects of preclinical drug discovery from target identification and validation through hit identification, lead identification and optimisation, to candidate selection.
Expert Opinion on Drug Delivery is a monthly peer-reviewed medical journal publishing review articles covering all aspects of research on drug delivery, from initial concept to potential therapeutic application and final relevance in clinical use. It was established in 2004 and is published by Taylor and Francis Group.
This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.
Drug Design, Development and Therapy; Drug Development and Industrial Pharmacy; Drug Discovery Today; Drug, Healthcare and Patient Safety; Drug Safety; Drug Metabolism Reviews; Drug Testing and Analysis; European Heart Journal - Cardiovascular Pharmacotherapy; European Journal of Pharmaceutical Sciences; European Journal of Pharmaceutics and ...
Pan-assay interference compounds, or PAINS, often come up as false positives when researchers screen for potential drug candidates. unol/iStock via Getty Images PlusModern drug discovery is an ...
This is a list of abbreviations used in medical prescriptions, including hospital orders (the patient-directed part of which is referred to as sig codes).This list does not include abbreviations for pharmaceuticals or drug name suffixes such as CD, CR, ER, XT (See Time release technology § List of abbreviations for those).
SLAS Discovery (Advancing the Science of Drug Discovery) is a peer-reviewed scientific journal published by the Society for Laboratory Automation and Screening (SLAS) in partnership with SAGE Publications. The editor-in-chief is Robert M. Campbell, Ph.D. (Eli Lilly and Company). The journal explores how scientists develop and utilize novel ...
It was established in 2002 [1] and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick. [ 2 ] According to the Journal Citation Reports , the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology" [ 3 ] and 1st out of 279 journals in the ...